| Name | Title | Contact Details |
|---|
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
BMP Medical is your preferred source for custom OEM injection molded medical devices. We are a privately held, veteran-owned company that has been in business for over 30 years. We use the most state of the art molding techniques and machinery to produce small to medium sized parts with very tight specifications. We also offer design consultation, engineering, drawing, R&D, tooling, mold development, computer automation, and statistical process control for mid-tier products. For our customer`s convenience, our facility is equipped with a Class 8 clean room for manufacturing, packaging, and assembly needs. BMP Medical has built its reputation on relationships and many of our OEM medical contract manufacturing customers have been with us for over 20 years. We look forward to introducing ourselves to new customers and building new relationships.
SunMedica is a Redding, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Gri Medical Products Inc is a Cave Creek, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Halyard Health is a medical technology company focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. We deliver clinically-superior products and solutions in infection prevention, surgical solutions, respiratory health, digestive health, pain management and IV therapy. Halyard Health became an independent company headquartered in Alpharetta, Georgia on November 1, 2014. Halyard operates 12 global manufacturing facilities with 16,500 employees worldwide – generating approximately $1.7 billion in net revenues. Halyard Health is traded on the New York Stock Exchange under the ticker symbol “HYH”.